Other
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Four
Caterpillar Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Four remained flat by 0.0% to $5.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Four shows relatively stable performance with a 0.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalHigher is better
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025Feb 13, 2026
How to read this metric
Predictable subsidy receipts help in long-term cash flow planning and liability management.
Detailed definition
This represents the expected cash inflows from government subsidies related to prescription drug benefits provided under...
Peer comparison
Standard disclosure for companies with significant legacy retiree healthcare liabilities.
Metric ID:
other_prescription_drug_subsidy_receipts_year_four1Historical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $5.00M | $5.00M | $5.00M |
| QoQ Change | — | +0.0% | +0.0% |
| YoY Change | — | +0.0% | +0.0% |
Range$5.00M – $5.00M
Avg YoY Growth+0.0%
Median YoY Growth+0.0%
Current Streak2+ quarters growth
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Four at Other Companies
Frequently Asked Questions
- What is Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year four?
- Caterpillar (CAT) reported defined benefit plan, expected future prescription drug subsidy receipt, year four of $5.00M in Q4 2025.
- What is the long-term trend for Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year four?
- Over 2 years (2023 to 2025), Caterpillar's defined benefit plan, expected future prescription drug subsidy receipt, year four has grown at a 0.0% compound annual growth rate (CAGR), from $5.00M to $5.00M.
- What does defined benefit plan, expected future prescription drug subsidy receipt, year four mean?
- Expected government payments for retiree prescription drug costs in the fourth year.